Improved synthesis of [¹⁸F]FS-PTAD as a new tyrosine-specific prosthetic group for radiofluorination of biomolecules

Appl Radiat Isot. 2015 Oct:104:136-42. doi: 10.1016/j.apradiso.2015.06.021. Epub 2015 Jun 20.

Abstract

A novel prosthetic group, 4-(p-([(18)F]fluorosulfonyl)phenyl)-1,2,4-triazoline-3,5-dione ([(18)F]FS-PTAD) for site-specific radiofluorination of tyrosine residue in small molecules is described. Coupling of [(18)F]FS-PTAD with L-tyrosine, N-acetyl-L-tyrosine methyl amide and phenol as model compounds were achieved in buffered aqueous solution at room temperature, resulting in the corresponding fluorinated tyrosine and phenol derivatives. The total synthesis time including radiosynthesis, HPLC purification and formulation was less than 60 min (n=15) with ≥98% radio chemical purity. An initial in vitro evaluation of [(18)F]FS-PTAD-tyrosine in glioma cell lines revealed moderate uptake.

Keywords: Ene-like reaction; Prosthetic group; Radiofluorination; Tyrosine conjugation; [(18)F]FS-PTAD.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Fluorine Radioisotopes / chemistry*
  • Fluorine Radioisotopes / pharmacokinetics*
  • Glioma / metabolism*
  • Halogenation
  • Humans
  • Isotope Labeling / methods*
  • Metabolic Clearance Rate
  • Radiopharmaceuticals / chemical synthesis
  • Radiopharmaceuticals / pharmacokinetics
  • Rats
  • Tyrosine / chemistry*
  • Tyrosine / pharmacokinetics*

Substances

  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Tyrosine